Our US based client established a company based on research from a US University that quantifies a unique protein/protein complex in cerebrospinal fluid (CSF) and serum that identifies AD subjects including those early in disease progression. More
A simple blood based assay to identify diabetic patients who are likely to develop or have early stage diabetic nephropathy has been developed at King's. This has the potential to be used regularly at diabetic clinics. More
An immuno-PCR method allowing the detection of proteins, carbohydrates, hormones, bacteria, organic components, aromatic compounds, infections agents,… in complex matrices. More